DNA Sequencing Firm Illumina Wants To Fight Cancer With Grail, A 'Liquid Biopsy' To Detect Cancer

San Diego-based DNA sequencing company Illumina plans to build startup Grail to offer liquid biopsy to the market. This cancer blood test is promoted by CEO Jay Flatley as the "turning point" in the war on cancer.